Syndax (SNDX) CMO sells 65,515 shares, retains 60,885 and large options
Syndax Pharmaceuticals' Head of R&D and CMO, Nicholas A.J. Botwood, engaged in an exercise-and-sell transaction, acquiring 53,750 shares through stock options at $13.82 per share and subsequently selling 65,515 shares in open-market transactions for approximately $18 per share. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan. Following these transactions, Botwood retains 60,885 common shares and a substantial number of vested and unvested options.
SkyWater Technology (SKYT) director awarded 4,304 RSUs in stock grant
SkyWater Technology director Tammy J. Miller has been awarded 4,304 restricted stock units (RSUs) as part of her compensation, rather than through an open-market purchase. These RSUs will vest just before the company's next annual meeting, contingent on her continued service. Following this grant, Miller directly owns 15,732 shares of common stock.
Advanced Micro Devices (NASDAQ:AMD) Trading Up 4.7% Following Analyst Upgrade
Advanced Micro Devices (NASDAQ: AMD) saw its stock price rise by 4.7% following an analyst upgrade from The Goldman Sachs Group. Bullish sentiment from Wall Street analysts remains, citing upside potential from AI GPUs, server demand, and agentic AI. The company reported strong Q1 earnings with $1.37 EPS and $10.25 billion in revenue, both exceeding expectations.
AES (NYSE: AES) sells $1.0B of senior notes — 5.20% 2029, 5.75% 2033
The AES Corporation has announced the pricing of $1.0 billion in senior notes, consisting of $600 million of 5.200% Senior Notes due 2029 and $400 million of 5.750% Senior Notes due 2033. The net proceeds, estimated at $992.0 million, are intended for the repayment of existing indebtedness and general corporate purposes. These unsecured obligations will pay interest semiannually starting January 15, 2027, and rank equally with AES’ other unsecured debt.
FDA approves Sanofi's drug for stage 3 type 1 diabetes in children
The U.S. Food and Drug Administration (FDA) has approved Sanofi's injection for children aged 8 to 17 recently diagnosed with stage 3 type 1 diabetes. This drug aims to slow the loss of the body's own insulin production. The approval was announced on Friday, June 12, 2026.
Abbott Laboratories (ABT) Announces Quarterly Dividend of $0.63
Abbott Laboratories (ABT) announced a quarterly dividend of $0.63 per share, maintaining consistency with previous distributions, which translates to a forward yield of 2.89%. This news comes as the company navigates a recent stock decline, with the dividend payable on August 17 to shareholders of record by July 15. The firm, boasting a GF Score of 80/100, demonstrates strong profitability and growth, despite a current P/E ratio that suggests potential undervaluation, and has seen insider buying activity.
Tyler Technologies (TYL) Announces New $150 Million Share Repurc
Tyler Technologies (TYL) has announced a new Rule 10b5-1 trading plan to repurchase up to $150 million of its common stock, scheduled to run from June 16, 2026, to July 30, 2026. This initiative is part of a larger $1 billion repurchase authorization approved in February 2026, with $332.7 million remaining under it. The program, funded by existing cash and credit facility borrowings, aims to enhance shareholder value and maintain financial flexibility.
Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
Lockheed Martin (NYSE:LMT) has been awarded two Defense Department contracts totaling approximately $2.8 billion. These contracts are for F-35 fighter jet sustainment and CH-53K helicopter development work. The larger contract, valued at $2.29 billion, is for sustainment activities and services for the F-35 Lightning II, while the second contract, worth up to $525 million, is for engineering and flight-test support for the CH-53K Heavy Lift Helicopter program.
Beyond the Orange Apron: Home Depot Stock’s Pro-Grade Opportunity
Home Depot's stock has underperformed, but the company is strategically shifting its focus from DIY consumers to professional contractors. By acquiring specialized distributors like SRS and Mingledorff’s, Home Depot is building a "Pro ecosystem" designed to be an indispensable partner for large remodelers and small homebuilders. This strategy has already yielded a projected $400 million in cross-sell revenue this year, with plans to double that next year, indicating a significant growth engine despite a challenging housing market.
Corteva raises restructuring charges, to shut Spain plant in cost-cut push
Corteva announced an increase in its expected restructuring charges to up to $815 million as part of a strategic initiative to streamline its crop protection network. This plan includes the shutdown of its plant located in Asturias, Spain. The move is aimed at deeper cost-cutting and network overhaul efforts, reflecting the company's commitment to optimizing its operations.



